• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Thromb Haemost Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

tetano

Editor, Senior Moderator
J Thromb Haemost. 2020 Apr 9. doi: 10.1111/jth.14830. [Epub ahead of print]
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.


Cui S[SUP]1[/SUP], Chen S[SUP]1[/SUP], Li X[SUP]1[/SUP], Liu S[SUP]2[/SUP], Wang F[SUP]3[/SUP].

Author information




Abstract

BACKGROUND:

Since 3 months ago, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China, and spread rapidly around the world. Severe novel coronavirus pneumonia (NCP) patients have abnormal blood coagulation function, but their venous thromboembolism(VTE) prevalence is still rarely mentioned.
OBJECTIVES:

To determine the incidence of VTE in patients with severe NCP.
METHODS:

In this study, 81 severe NCP patients in the Intensive Care Unit (ICU) of Union Hospital (Wuhan, China) were enrolled. The results of conventional coagulation parameters and lower limb vein ultrasonography of these patients were retrospectively collected and analyzed.
RESULTS:

The incidence of VTE in these patients was 25%(20/81), of which 8 patients with VTE events died. VTE group was different from non-VTE group in age, lymphocytes counts, activated partial thromboplastin time (APTT), D-dimer, etc. If 1.5 ?g/mL was used as the D-dimer cut-off value to predicting VTE, the sensitivity was 85.0%, the specificity was 88.5% and the negative predictive value (NPV) was 94.7%.
CONCLUSIONS:

The incidence of VTE in patients with severe NCP is 25% (20/81), which may be related to poor prognosis. The significant increase of D-dimer in severe NCP patients is a good index for identifying high-risk groups of VTE.
This article is protected by copyright. All rights reserved.



KEYWORDS:

D-dimer; blood coagulation; coagulation parameter; novel coronavirus pneumonia; venous thromboembolism


PMID:32271988DOI:10.1111/jth.14830
 
Back
Top